Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Is Colon Resection or CME Surgery More Successful?

Disease-free survival rates in patients with colon adenocarcinoma

In patients with stage I to III colon adenocarcinoma, complete mesocolic excision (CME) surgery is associated with better disease-free survival than conventional colon resection and should be more widely implemented, according to a review of 1,391 patients with colon cancer.

Four-year disease-free survival rates were highest among CME patients, regardless of cancer stage, as follows:

CME

Non-CME

population

363

1,031

Survival, all stages

85.8%

75.9%

Survival, stage I

100%

89.8%

Survival, stage II

91.9%

77.9%

Survival, stage III

75.3%

67.5%

Citation: Bertelsen CA, Neuenschwander AU, Jansen JE, et al; Danish Colorectal Cancer Group. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol. 2015;16(2):161-168. doi: 10.1016/S1470-2045(14)71168-4.